Redeye: Doro - The patient feels better

mån, maj 07, 2018 07:55 CET

Doro's EBIT margin in Q1 reached 6 percent, which is the average margin in our base case of SEK 56. The current market expectations seems to be significantly lower than that.

Read more in the Research Update by Viktor Westman at: https://goo.gl/h7Gjyj

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/